XML 30 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jan. 28, 2012
Jan. 29, 2011
Jan. 30, 2010
OPERATING ACTIVITIES:      
Net loss $ (48,064) $ (25,868) $ (41,998)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:      
Depreciation and amortization 12,827 13,337 14,320
Share-based payment compensation 5,007 3,350 3,205
Amortization of deferred revenue (1,061) (728) (715)
Amortization of debt discount 575 2,121 181
Amortization of deferred finance costs 609 305 0
Gain on sale of investments 0 0 (3,628)
Gain from disposal of equipment (416) 0 0
Asset impairments and write-offs 0 809 1,446
Loss on debt extinguishment 25,679 1,235 0
Changes in operating assets and liabilities:      
Accounts receivable 9,909 (21,292) (17,581)
Inventories, net (3,676) 4,277 6,980
Prepaid expenses and other (460) 348 (493)
Deferred revenue 500 0 31
Accounts payable and accrued liabilities (15,447) 16,768 (4,325)
Accrued dividends payable — Series B Preferred Stock 1,069 5,665 4,681
Net cash provided by (used for) operating activities (12,949) 327 (37,896)
INVESTING ACTIVITIES:      
Property and equipment additions (11,096) (7,584) (7,578)
Proceeds from sale of short and long-term investments 0 0 19,356
Proceeds from disposal of equipment 416 55 0
Change in restricted cash and investments 2,861 99 (3,471)
Net cash used for investing activities (7,819) (7,430) 8,307
FINANCING ACTIVITIES:      
Payments for repurchases of common stock 0 0 (937)
Payment on redemption of Series A preferred stock 0 0 (3,400)
Payment for Series B Preferred stock redemption 0 0 (3,648)
Payments for deferred issuance costs (306) (3,292) 0
Payment for Series B Preferred stock dividend (8,915) (2,500) 0
Payments for Series B Preferred Stock and other issuance costs (40,853) 0 0
Proceeds from exercise of stock options 1,828 357 729
Proceeds from issuance of term loan 0 25,000 0
Procceeds from issuance of common stock, net 55,500 17,009 0
Net cash provided by (used for) financing activities 7,254 36,574 (7,256)
Net increase (decrease) in cash and cash equivalents (13,514) 29,471 (36,845)
BEGINNING CASH AND CASH EQUIVALENTS 46,471 17,000 53,845
ENDING CASH AND CASH EQUIVALENTS $ 32,957 $ 46,471 $ 17,000